COLUMBIA, Md.--(BUSINESS WIRE)--Scientific & Biomedical Microsystems, LLC, a developer of scientific and medical sensors and systems based on MEMS (micro-electro-mechanical systems) and other microfabrication technologies, today announced it has been awarded a five-year Schedule 871 contract by the U.S. General Services Administration (GSA). The contract will streamline the ability of all United States Federal agencies and contractors to purchase SB Microsystems’ advanced design, fabrication and test services.
The twelve-person, five -year-old company also announced a series of other developments which highlight its technological capabilities, business competitiveness and growth:
- two new hires recently joined the company, with two more openings announced and candidates now being interviewed
- company representatives will take part in Governor O’Malley’s Investment and Trade Mission to India (Nov. 28-Dec. 3)
- SB Microsystems is working with the Applied Physics and Instrumentation Group (APIG) at the Howard Hughes Medical Institute’s Janelia Farm campus, to develop a family of next-generation silicon neural recording probes for studying neurophysiology at the systems level
- the company recently was engaged by Rapid Diagnostek, Inc., for the development of cutting-edge point-of-care devices designed to improve human, veterinary, environmental, and food testing capabilities
SB Microsystems’ core capabilities include MEMS, microfluidics, embedded systems, precision machining, biosensors and wireless sensor networks. It provides a full scope of early-stage product development services from concept development and detailed design all the way through to prototype fabrication, test, and manufacturing. Current projects include the development of miniature analytical instruments, point-of-care instrumentation and implantable medical and biological sensors.
“Our ability to span the range of design, production and test sets us apart from competitors, which tend to be either R&D services firms lacking the ability to do miniaturization, or foundries mainly focused on production,” said Brian Jamieson, President. “We are detail oriented, but not bogged down in details. We are smart, yet eminently practical. Creative, driven, optimistic, fun – not your typical engineers.
“SB Microsystems was founded to serve our clients by helping them develop novel solutions to challenging problems in biology and medicine and to bring new products to the market.”
The Schedule 871 contract takes effect September 27th 2011.
For more information about Scientific & Biomedical Microsystems, please visit http://www.sbmicrosystems.us/index.html